Crystal structure at 1.95 å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition-Reference-Cited by-同舟云学术

Crystal structure at 1.95 å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition

Published:1998-12 Issue:3 Volume:284 Page:713-728
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Dokurno Pawel,Bates Paul A,Band Heather A,Stewart Lorna M.D,Lally John M,Burchell Joy M,Taylor-Papadimitriou Joyce,Snary David,Sternberg Michael J.E,Freemont Paul S

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference61 articles.

1. Standard conformations for the canonical structures of immunoglobulins;Al-Lazikani;J. Mol. Biol.,1997

2. A conformation of cyclosporine-A in aqueous environment revealed by the X-ray structure of a cyclosporine-Fab complex;Altschuh;Science,1992

3. Crystal structure of the Fab fragment of a monoclonal antibody specific for carcinoembryonic antigen;Banfield;Acta Crystallog. sect D,1996

4. VL:VH domain rotations in engineered antibodies;Banfield;Proteins: Struct. Funct. Genet.,1997

5. Conformational analysis of the first observed non-proline cis-peptide bond occuring within the complementary determining region (CDR) of an antibody;Bates;J. Mol. Biol.,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of Tumor‐Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes;Angewandte Chemie International Edition;2024-08-07

2. Detection of Tumor‐Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes;Angewandte Chemie;2024-08-07

3. Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing;Life Science Alliance;2024-03-20

4. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses;JACS Au;2023-11-21

5. Reverse engineering the anti-MUC1 hybridoma antibody 139H2 by mass spectrometry-basedde novosequencing;2023-07-05